Figure 1
Figure 1. Structural locations of fibrinogen variants in patients with CTEPH. The positions of the alterations expected from the various mutations are illustrated on a ribbon model of chicken fibrinogen.21 In fibrinogenSan Diego I, the oligosaccharides attached to Bβ Asn-364 and γ Asn-52 are excessively disialylated, which imparts negative charges to the regions, thereby promoting the formation of “thin” fibrin fibers.22,23 A similar situation exists for fibrinogenSan Diego V (Aα R554H), in which the arginine→histidine substitution would also reduce the net charge in that region (not shown because it occurs in a region too flexible for crystallographic resolution). In fibrinogenSan Diego II (γ Y114H) and fibrinogenSan Diego IV (Aα L69H) the substitutions result in the insertion of a polar imidazole side chain within the “helix-permissive” hydrophobic center of the coiled coil,24 which could disrupt the molecular structure. In fibrinogensSan Diego I-III, the Bβ P235L substitution occurs at an articulation site in the βC region that ordinarily allows exposure of a t-PA binding site within the coiled coil. Substitution of leucine for the conformationally rigid proline in this area could affect the flexibility between the βC region and the coiled coil,14 which normally allows exposure of a region (circa Aα-157) that has been implicated in the activation of t-PA by fibrin.25

Structural locations of fibrinogen variants in patients with CTEPH. The positions of the alterations expected from the various mutations are illustrated on a ribbon model of chicken fibrinogen.21  In fibrinogenSan Diego I, the oligosaccharides attached to Bβ Asn-364 and γ Asn-52 are excessively disialylated, which imparts negative charges to the regions, thereby promoting the formation of “thin” fibrin fibers.22,23  A similar situation exists for fibrinogenSan Diego V (Aα R554H), in which the arginine→histidine substitution would also reduce the net charge in that region (not shown because it occurs in a region too flexible for crystallographic resolution). In fibrinogenSan Diego II (γ Y114H) and fibrinogenSan Diego IV (Aα L69H) the substitutions result in the insertion of a polar imidazole side chain within the “helix-permissive” hydrophobic center of the coiled coil,24  which could disrupt the molecular structure. In fibrinogensSan Diego I-III, the Bβ P235L substitution occurs at an articulation site in the βC region that ordinarily allows exposure of a t-PA binding site within the coiled coil. Substitution of leucine for the conformationally rigid proline in this area could affect the flexibility between the βC region and the coiled coil,14  which normally allows exposure of a region (circa Aα-157) that has been implicated in the activation of t-PA by fibrin.25 

Close Modal

or Create an Account

Close Modal
Close Modal